In 2012, the FDA approved the first new prescription weight loss drug in thirteen years: lorcaserin, marketed as Belviq. Available to patients in the US since June 2013 in a twice-daily dose, it was soon (2016) followed by once-a-day Belviq XR. Expectations crushed Nevertheless, this herald of hope for almost one third of Americans rated…